| LABORATORIES SERONO SA Patent applications |
| Patent application number | Title | Published |
|---|
| 20100021429 | CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS - The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy. | 01-28-2010 |
| 20090176761 | JNK Inhivitors for the Treatment of Endometriosis - This invention relates to a method of treating and/or preventing endometriosis comprising administering a JNK inhibitor. The JNK inhibitor can also be administered combined with a hormonal suppressor. The invention further relates to the treatment of endometriosis-related infertility | 07-09-2009 |
| 20090169506 | USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY - The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred. | 07-02-2009 |
| 20080306057 | P13K Inhibitors for the Treatment of Endometriosis - This invention relates to a method of treating and/or preventing endometriosis comprising administering a PI3K inhibitor. The PI3K inhibitor can also be administered combined with a hormonal suppressor. The invention further relates to the treatment of endometriosis-related infertility. | 12-11-2008 |
| 20080253996 | Use of Sdf-1 for the Treatment and/or Prevention of Neurological Diseases - The invention relates to the use of SDF-1, or of an agonist of SDF-1 activity, for the treatment and/or prevention of a neurological disease. | 10-16-2008 |
| 20080221180 | Thiazole Derivatives and Use Thereof - The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries. | 09-11-2008 |
| 20080207722 | Glepp-1 Inhibitors in the Treatment of Autoimmune and/or Inflammatory Disorders - The present invention is related to the use of a Glepp-1 inhibitor for the manufacture of a medicament for the treatment of an autoimmune and/or an inflammatory disorder. | 08-28-2008 |
